Growth through AI Splose is actively positioning AI and automation as core to its product, signaling readiness to upsell advanced AI-driven practice management capabilities and integration with AI services to larger clinics seeking efficiency gains.

Series A traction Recent $46M Series A funding and high-profile investment indicate growing market validation and budget availability in healthcare software, creating a favorable environment for expanding into new practice types and geographies.

Integrations advantage Existing integrations with Recoverymetrics and other tools, plus a tech stack including Snowflake, Redshift, and cloud platforms, suggest a strong foundation for cross-sell with analytics, billing, and EMR-adjacent solutions to mid-market practices.

Competitive positioning Competitor mentions in industry coverage highlight a crowded PMS space; emphasize Splose differentiators such as automated invoice reminders, case alerts, and AI-assisted automation to capture practitioners evaluating multiple vendors.

Financing signal Multi-year revenue trajectory and mid-market price band indicate target clinics likely in the $10–25M revenue range; sales outreach can prioritize clinics expanding operations, multi-site practices, and allied health segments seeking scalable PMS upgrades.